LCI INDS Stock Price, News & Analysis
Company Description
LCI INDS (OTC: LCIN) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $164.7K.
LCIN stock has declined 95.8% over the past year.
This page provides a comprehensive overview of LCIN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
LCI INDS (LCIN) stock. Over the past 12 months, the stock has lost 95.8%. At a market capitalization of $164.7K, LCIN is classified as a micro-cap stock with approximately 10.8M shares outstanding.
Latest News
LCI INDS has 2 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. View all LCIN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
LCIN Company Profile & Sector Positioning
LCI INDS (LCIN) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing LCIN often look at related companies in the same sector, including Clarus Therapeutics Holdings Inc (CRXTQ), (CADMD), (ATNX), Mallinckrodt Plc (MNKKQ), and (GENH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LCIN's relative position within its industry.